Divi’s Laboratories reported consolidated net profit increased almost 68% to ₹538 crore for the quarter ended March 2024 on the back of a revenue from operations that was 18% higher. Revenue from operations of the active pharmaceutical ingredients, intermediates and nutraceutical ingredients maker increased to ₹2,303 crore (₹1,951 crore). The company had posted ₹321 crore net profit in the year earlier.
The company has declared a final dividend of ₹30 per equity share of face value ₹2 each for 2023-24. For the full fiscal, it reported consolidated revenue from operations increased to ₹7,845 crore (₹7,767 crore) while net profit declined to ₹1,600 crore (₹1,824 crore).
Denial of responsibility! Pioneer Newz is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.
